Additional Methods and Results
2 or LLC-MK2 cells in a TCID 50 assay (for quantification of hMPV). HEp-2a cells were exposed to a 10-fold dilution series of RSV-infected supernatants for 2 h, then overlayed with 0.8% methyl cellulose / OptiMEM / 2% FCS, and incubated for 6 days at 37 o C. Monolayers were then fixed and RSV-positive plaques identified using anti-RSV polyserum (Virostat).
The quantity of RSV in cell culture supernatants was then calculated as pfu / ml. LLC-MK2 cells were exposed to a 10-fold dilution series of hMPV-infected supernatants for 2 h, then the cells washed and incubated for 8 days at 37 o C, after which time they were fixed and hMPV-positive monolayers identified using anti-hMPV antiserum (Ursula Buchholz, NIAID, NIH). The quantity of hMPV in cell culture supernatants was then calculated as a TCID 50 value using the Karber formula.
RNA extraction and qPCR
Total RNA was extracted from cells infected at a MOI of 3, and RT-qPCR performed to quantify intracellular viral RNA as a measure of viral replication, and also to quantify cellular gene expression. Total RNA was extracted using TRIzol (Life Technologies)/chloroform phase separation and isopropanol precipitation. RNA was DNase treated (Ambion), and RT performed using random hexamers (Applied Biosystems). RSV and hMPV specific primers were used to quantify vRNA copy number against control plasmids containing the RSV or hMPV nucleoprotein (N). vRNA was normalized to β-actin copy number, also quantified using specific primers and an expression plasmid. The expression of IRF7, Mx1 and IL-33 mRNA was quantified relative to β-actin, and expressed as fold induction over uninfected cells using the 2 -ΔΔCt equation. Primer sequences are listed in Table S1 . h e a lth y w h e e z e a lo n e a to p y a lo n e w h e e z e a n d a to p y h e a lth y w h e e z e a lo n e a to p y a lo n e w h e e z e a n d a to p y h e a lth y w h e e z e a lo n e a to p y a lo n e w h e e z e a n d a to p y 
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